OR WAIT null SECS
September 04, 2009
Sanofi aventis has finished implementing Lanner's process simulation software into one of its major UK sites following a successful Phase I implementation in which the company made more than £1 million in inventory cost savings in 6 months.
September 03, 2009
Also, Orexo and Novartis form agreement; Affitech appoints Robert Burns CEO; more...
September 02, 2009
After years of promomting QbD concepts, FDA's ready to take action on nonconformers.
Robotic systems provide flexibility and efficiency (and they're not as difficult to use as you think). This article contains bonus online-exclusive material.
As new process validation guidelines emerge, industry needs to reinvent how it releases product.
September 01, 2009
When validating automated systems from third-party providers, using the V model and failure modes effects and criticality analysis (FMECA) early in the process can help.
August 27, 2009
Company and People Notes: UCB and Novartis form agreement; AAIPharma appoints VP of regulatory affairs; more...
August 20, 2009
Also, FDA publishes draft guidances of two ICH Annexes; EMEA sets format for compliance advice; more...
Also, XCELERON and GSK form agreement; Millipore appoints VP of life sciences; more...
August 13, 2009
Also: DSM's North Carolina facility receives SafeBridge certification; Dynavax CFO to retire; more...